A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

A research team at the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has developed a new ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

PITTSBURGH (KDKA) — A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was created to detect the disease in the brain earlier.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

CHARLOTTESVILLE, Va. (WVIR) -A promising new study could bring us closer to finding better treatments for Alzheimer’s disease. One expert and her team are studying how tiny changes in brain ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...